Literature DB >> 22156937

Recent trends in the treatment of prolonged grief.

Anthony D Mancini1, Paul Griffin, George A Bonanno.   

Abstract

PURPOSE OF REVIEW: Treatment for prolonged grief has been controversial. However, recent studies have clarified several key issues, offering important guidance to clinicians. This review summarizes the most recent evidence on the efficacy of grief treatments, moderators of treatment response, and new treatment approaches. RECENT
FINDINGS: Recent research findings highlight that grief therapy is efficacious when targeted to adult and child grievers with persistent and elevated levels of distress. However, when grief therapy is applied as a universal intervention, it has minimal to no benefits, either for adults or for children. Earlier intervention for children is associated with greater efficacy. In recent studies, therapies employing cognitive-behavioral techniques, such as cognitive restructuring and exposure, have shown particularly robust effects in ameliorating grief symptoms. Other intervention approaches, including pharmacotherapy, internet-based, family-based, and preventive, have shown initial promise, but insufficient data exist to validate their efficacy to date.
SUMMARY: Prolonged grief, a pattern of persistent and elevated distress following a loss, is increasingly recognized as an independent form of psychopathology that is responsive to treatment. Therapies that employ cognitive-behavioral techniques are efficacious in ameliorating the symptoms of prolonged grief and should be more widely used. However, grief therapy should not be deployed as a blanket intervention for all grievers. Antidepressant medication may serve a useful adjunctive role in grief therapy completion and in reducing bereavement-related depression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22156937     DOI: 10.1097/YCO.0b013e32834de48a

Source DB:  PubMed          Journal:  Curr Opin Psychiatry        ISSN: 0951-7367            Impact factor:   4.741


  8 in total

1.  Pre-loss personal factors and prolonged grief disorder in bereaved mothers.

Authors:  Richard D Goldstein; Carter R Petty; Sue E Morris; Melanie Human; Hein Odendaal; Amy Elliott; Deb Tobacco; Jyoti Angal; Lucy Brink; Hannah C Kinney; Holly G Prigerson
Journal:  Psychol Med       Date:  2018-11-09       Impact factor: 7.723

2.  Evidence of the clinical utility of a prolonged grief disorder diagnosis.

Authors:  Wendy G Lichtenthal; Paul K Maciejewski; Caraline Craig Demirjian; Kailey E Roberts; Michael B First; David W Kissane; Robert A Neimeyer; William Breitbart; Elizabeth Slivjak; Greta Jankauskaite; Stephanie Napolitano; Andreas Maercker; Holly G Prigerson
Journal:  World Psychiatry       Date:  2018-10       Impact factor: 49.548

3.  Disciplinary Wounds: Has Grief Become the Identified Patient for a Field Gone Awry?

Authors:  Leeat Granek
Journal:  J Loss Trauma       Date:  2012-12-26

4.  Psychological Outcomes after Critical Illness. Is It Time to Rethink Our Paradigm?

Authors:  May Hua
Journal:  Am J Respir Crit Care Med       Date:  2018-01-01       Impact factor: 21.405

5.  Prevalence and predictors of severe grief reactions and desire for support following a death in the intensive care unit: a multicentre observational study.

Authors:  James Downar; Ellen Koo; Amanda Roze des Ordons; Orla Smith; Deborah Cook; Eyal Golan; Sarah Hales; George Tomlinson; Csilla Kalocsai; Derek Strachan; Christopher MacKinnon; Tasnim Sinuff
Journal:  Intensive Care Med       Date:  2017-12-28       Impact factor: 17.440

6.  Treating complicated grief.

Authors:  Naomi M Simon
Journal:  JAMA       Date:  2013-07-24       Impact factor: 56.272

7.  Assessment of Emotional Experience and Emotional Recognition in Complicated Grief.

Authors:  Manuel Fernández-Alcántara; Francisco Cruz-Quintana; M N Pérez-Marfil; Andrés Catena-Martínez; Miguel Pérez-García; Oliver H Turnbull
Journal:  Front Psychol       Date:  2016-02-12

8.  Job loss-related complicated grief symptoms: A cognitive-behavioral framework.

Authors:  Janske H W Van Eersel; Toon W Taris; Paul A Boelen
Journal:  Front Psychiatry       Date:  2022-07-22       Impact factor: 5.435

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.